Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Formative Research

Date Submitted: Jul 12, 2024
Open Peer Review Period: Jul 12, 2024 - Sep 6, 2024
Date Accepted: Nov 24, 2024
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

Insights From Diverse Perspectives on Social Media Messages to Inform Young Adults With Cancer About Clinical Trials: Focus Group Study

Beauchemin MP, Walker D, Rosen A, Frazer M, Eisenberger M, Khurana RK, Bentlyewski E, Fedorko V, Basch CH, Hillyer GC

Insights From Diverse Perspectives on Social Media Messages to Inform Young Adults With Cancer About Clinical Trials: Focus Group Study

JMIR Form Res 2025;9:e64265

DOI: 10.2196/64265

PMID: 39864817

PMCID: 11769686

Diverse perspectives on social media messages to inform young adults with cancer about clinical trials: Insights from focus groups

  • Melissa P. Beauchemin; 
  • Desiree Walker; 
  • Allison Rosen; 
  • Maria Frazer; 
  • Meital Eisenberger; 
  • Rhea K.. Khurana; 
  • Edward Bentlyewski; 
  • Victoria Fedorko; 
  • Corey H. Basch; 
  • Grace C. Hillyer

ABSTRACT

Background:

Low rates of adolescent and young adult (AYA) clinical trial enrollment (CTE), particularly among underserved groups, have resulted in a lack of standardized cancer treatments and follow-up guidelines for this group that may limit improvement in cancer treatments and survival outcomes for AYAs.

Objective:

To understand and address unique barriers to CTE, we conducted focus groups to learn about informational, financial, and psychosocial needs of AYAs surrounding CTE and identify strategies to address these barriers.

Methods:

We conducted five focus groups in 2023 among a diverse sample of AYA patients from across the U.S. An interview guide was developed collaboratively with AYA advocates. Specifically, informational needs, financial concerns, and psychosocial issues were explored, and participants were probed to suggest strategies, especially those that leverage technology, to address these barriers. Sessions were audio recorded, transcribed, and coded using direct content analysis. Findings were synthesized through consensus discussions.

Results:

We confirmed the previously proposed thematic barriers regarding AYA CTE, and identified nine sub-themes: awareness, lack of clear and accessible CTE information, fear of the unknown, assumptions about costs, insurance coverage, navigating financial responsibilities, clinical trial discussions, clinical trial misconceptions, and desire for a support network. Throughout, AYAs mentioned needs that might be addressed through informational outreach leveraging technology, the internet, and social media.

Conclusions:

This study expands knowledge of AYA perceived barriers to CTE. These findings suggest that leveraging technology to disseminate reliable information to address needs may be an effective strategy to improve clinical trial participation in the AYA population. Clinical Trial: Not appliable.


 Citation

Please cite as:

Beauchemin MP, Walker D, Rosen A, Frazer M, Eisenberger M, Khurana RK, Bentlyewski E, Fedorko V, Basch CH, Hillyer GC

Insights From Diverse Perspectives on Social Media Messages to Inform Young Adults With Cancer About Clinical Trials: Focus Group Study

JMIR Form Res 2025;9:e64265

DOI: 10.2196/64265

PMID: 39864817

PMCID: 11769686

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.